ALK+ lung cancer
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
ALK+ lung cancer
Sep 6, 2024, 11:02 |
Insight
Iván R. González: Advances in the treatment of advanced ALK+ lung cancer
Iván R. González, Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla, shared a post…
Sep 2, 2024, 17:09 |
Insight
Genetic interactions that shape tumorigenesis
Vincent Lam, medical oncologist at Johns Hopkins Kimmel Cancer Center, shared a post by Monte…
Aug 12, 2024, 12:11 |
Blog
Narjust Florez: What a honor to discuss young lung cancer and ALK + lung cancer with people of Latin America
Narjust Florez, Associative Director CCEP & Thoracic Oncologist at Dana-Farber News, shared a post on X:…
Jun 24, 2024, 02:19 |
Blog
Narjust Florez: Discussing the management of ALK and lung cancer with NP McDonald
Narjust Florez shared on X: …
Jun 16, 2024, 17:20 |
Insight
Yvonne Diaz: EU Medicines Agency has approved Alecensa (alectinib) for early stage stage ALK+ lung cancer
Yvonne Diaz, Co-founder of Oncogene Cancer Research, shared a post on X: “Great to see that…
All:
5
Posts:
1 - 100
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube